Number of items: 41.
Article
Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trial. (2015)
Arenas-Pinto, Alejandro; Thompson, Jennifer; Musoro, Godfrey; Musana, Hellen; Lugemwa, Abbas; Kambugu, Andrew; Mweemba, Aggrey; Atwongyeire, Dickens; Thomason, Margaret J; Walker, A Sarah; Paton, Nicholas I; EARNEST Trial Team
Stepped wedge randomised controlled trials: systematic review of studies published between 2010 and 2014. (2015)
Beard, Emma; Lewis, James J; Copas, Andrew; Davey, Calum; Osrin, David; Baio, Gianluca; Thompson, Jennifer A; Fielding, Katherine L; Omar, Rumana Z; Ononge, Sam; Hargreaves, James; Prost, Audrey
Designing a stepped wedge trial: three main designs, carry-over effects and randomisation approaches. (2015)
Copas, Andrew J; Lewis, James J; Thompson, Jennifer A; Davey, Calum; Baio, Gianluca; Hargreaves, James R
Analysis and reporting of stepped wedge randomised controlled trials: synthesis and critical appraisal of published studies, 2010 to 2014. (2015)
Davey, Calum; Hargreaves, James; Thompson, Jennifer A; Copas, Andrew J; Beard, Emma; Lewis, James J; Fielding, Katherine L
Statistical methods for non-adherence in non-inferiority trials: useful and used? A systematic review. (2022)
Dodd, Matthew; Fielding, Katherine; Carpenter, James R; Thompson, Jennifer A; Elbourne, Diana
Cluster randomized trials of individual-level interventions were at high risk of bias. (2021)
Easter, Christina; Thompson, Jennifer A; Eldridge, Sandra; Taljaard, Monica; Hemming, Karla
Sample Size Calculations for Population Size Estimation Studies Using Multiplier Methods With Respondent-Driven Sampling Surveys. (2017)
Fearon, Elizabeth; Chabata, Sungai T; Thompson, Jennifer A; Cowan, Frances M; Hargreaves, James R
Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial. (2018)
Hakim, James G; Thompson, Jennifer; Kityo, Cissy; Hoppe, Anne; Kambugu, Andrew; van Oosterhout, Joep J; Lugemwa, Abbas; Siika, Abraham; Mwebaze, Raymond; Mweemba, Aggrey; Abongomera, George; Thomason, Margaret J; Easterbrook, Philippa; Mugyenyi, Peter; Walker, A Sarah; Paton, Nicholas I; Europe Africa Research Network for Evaluation of Second-line The
Five questions to consider before conducting a stepped wedge trial. (2015)
Hargreaves, James R; Copas, Andrew J; Beard, Emma; Osrin, David; Lewis, James J; Davey, Calum; Thompson, Jennifer A; Baio, Gianluca; Fielding, Katherine L; Prost, Audrey
Quality of stepped-wedge trial reporting can be reliably assessed using an updated CONSORT: crowd-sourcing systematic review. (2019)
Hemming, Karla; Carroll, Kelly; Thompson, Jennifer; Forbes, Andrew; Taljaard, Monica; SW-CRT Review Group
Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration. (2018)
Hemming, Karla; Taljaard, Monica; McKenzie, Joanne E; Hooper, Richard; Copas, Andrew; Thompson, Jennifer A; Dixon-Woods, Mary; Aldcroft, Adrian; Doussau, Adelaide; Grayling, Michael; Kristunas, Caroline; Goldstein, Cory E; Campbell, Marion K; Girling, Alan; Eldridge, Sandra; Campbell, Mike J; Lilford, Richard J; Weijer, Charles; Forbes, Andrew B; Grimshaw, Jeremy M
HIV-1 viral load and resistance in genital secretions in patients taking protease-inhibitor-based second-line therapy in Africa. (2017)
Hoppe, Anne; Giuliano, Marina; Lugemwa, Abbas; Thompson, Jennifer A; Floridia, Marco; Walker, Ann S; Senoga, Ismail; Abwola, Mary C; Pirillo, Maria F; Kityo, Cissy M; Arenas-Pinto, Alejandro; Paton, Nicholas I; EARNEST Trial Team
Poor outcomes in hospitalized patients with gastrointestinal bleeding: impact of baseline risk, bleeding severity, and process of care. (2014)
Jairath, Vipul; Thompson, J; Kahan, BC; Daniel, R; Hearnshaw, SA; Travis, SPL; Murphy, MF; Palmer, KR; Logan, RFA
Measuring the unknown: An estimator and simulation study for assessing case reporting during epidemics. (2022)
Jarvis, Christopher I; Gimma, Amy; Finger, Flavio; Morris, Tim P; Thompson, Jennifer A; le Polain de Waroux, Olivier; Edmunds, W John; Funk, Sebastian; Jombart, Thibaut
Neurocognitive Function at the First-Line Failure and on the Second-Line Antiretroviral Therapy in Africa: Analyses From the EARNEST Trial. (2016)
Kambugu, Andrew; Thompson, Jennifer; Hakim, James; Tumukunde, Dinah; van Oosterhout, Joep J; Mwebaze, Raymond; Hoppe, Anne; Abach, James; Kwobah, Charles; Arenas-Pinto, Alejandro; Walker, Sarah A; Paton, Nicholas I; EARNEST Trial Team
HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa. (2017)
Kityo, Cissy; Thompson, Jennifer; Nankya, Immaculate; Hoppe, Anne; Ndashimye, Emmanuel; Warambwa, Colin; Mambule, Ivan; van Oosterhout, Joep J; Wools-Kaloustian, Kara; Bertagnolio, Silvia; Easterbrook, Philippa J; Mugyenyi, Peter; Walker, A Sarah; Paton, Nicholas I; Europe Africa Research Network for Evaluation of Second-line The
Intra-cluster correlations from the CLustered OUtcome Dataset bank to inform the design of longitudinal cluster trials. (2021)
Korevaar, Elizabeth; Kasza, Jessica; Taljaard, Monica; Hemming, Karla; Haines, Terry; Turner, Elizabeth L; Thompson, Jennifer A; Hughes, James P; Forbes, Andrew B
Phase II trial of standard versus increased transfusion volume in Ugandan children with acute severe anemia. (2014)
Olupot-Olupot, Peter; Engoru, Charles; Thompson, Jennifer; Nteziyaremye, Julius; Chebet, Martin; Ssenyondo, Tonny; Dambisya, Cornelius M; Okuuny, Vicent; Wokulira, Ronald; Amorut, Denis; Ongodia, Paul; Mpoya, Ayub; Williams, Thomas N; Uyoga, Sophie; Macharia, Alex; Gibb, Diana M; Walker, A Sarah; Maitland, Kathryn
Assessment of second-line antiretroviral regimens for HIV therapy in Africa. (2014)
Paton, Nicholas I; Kityo, Cissy; Hoppe, Anne; Reid, Andrew; Kambugu, Andrew; Lugemwa, Abbas; van Oosterhout, Joep J; Kiconco, Mary; Siika, Abraham; Mwebaze, Raymond; Abwola, Mary; Abongomera, George; Mweemba, Aggrey; Alima, Hillary; Atwongyeire, Dickens; Nyirenda, Rose; Boles, Justine; Thompson, Jennifer; Tumukunde, Dinah; Chidziva, Ennie; Mambule, Ivan; Arribas, Jose R; Easterbrook, Philippa J; Hakim, James; Walker, A Sarah; Mugyenyi, Peter; EARNEST Trial Team
Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial. (2017)
Paton, Nicholas I; Kityo, Cissy; Thompson, Jennifer; Nankya, Immaculate; Bagenda, Leonard; Hoppe, Anne; Hakim, James; Kambugu, Andrew; van Oosterhout, Joep J; Kiconco, Mary; Bertagnolio, Silvia; Easterbrook, Philippa J; Mugyenyi, Peter; Walker, A Sarah; Europe Africa Research Network for Evaluation of Second-line The
Mapping the medical outcomes study HIV health survey (MOS-HIV) to the EuroQoL 5 Dimension (EQ-5D-3 L) utility index. (2019)
Shi, Yuan; Thompson, Jennifer; Walker, A Sarah; Paton, Nicholas I; Cheung, Yin Bun; EARNEST Trial Team
Forgiveness Is the Attribute of the Strong: Nonadherence and Regimen Shortening in Drug-sensitive Tuberculosis. (2022)
Stagg, Helen R; Thompson, Jennifer A; Lipman, Marc CI; Sloan, Derek J; Flook, Mary; Fielding, Katherine L
picture_as_pdf
Robust analysis of stepped wedge trials using cluster-level summaries within periods. (2018)
Thompson, JA; Davey, C; Fielding, K; Hargreaves, JR; Hayes, RJ
Comparison of small-sample standard-error corrections for generalised estimating equations in stepped wedge cluster randomised trials with a binary outcome: A simulation study. (2020)
Thompson, JA; Hemming, K; Forbes, A; Fielding, K; Hayes, R
Bias and inference from misspecified mixed-effect models in stepped wedge trial analysis. (2017)
Thompson, Jennifer A; Fielding, Katherine L; Davey, Calum; Aiken, Alexander M; Hargreaves, James R; Hayes, Richard J
The optimal design of stepped wedge trials with equal allocation to sequences and a comparison to other trial designs. (2017)
Thompson, Jennifer A; Fielding, Katherine; Hargreaves, James; Copas, Andrew
Better Evidence for Programmatic Approaches to Routine Syphilis Testing Among Men Living With Human Immunodeficiency Virus: Does a Stepped Wedge Trial Provide the Answer? (2021)
Thompson, Jennifer A; Francis, Suzanna C
Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial. (2018)
Thompson, Jennifer A; Kityo, Cissy; Dunn, David; Hoppe, Anne; Ndashimye, Emmanuel; Hakim, James; Kambugu, Andrew; van Oosterhout, Joep J; Arribas, Jose; Mugyenyi, Peter; Walker, A Sarah; Paton, Nicholas I; Europe–Africa Research Network for Evaluation of Second-line The
Cluster randomised trials with a binary outcome and a small number of clusters: comparison of individual and cluster level analysis method. (2022)
Thompson, Jennifer A; Leyrat, Clemence; Fielding, Katherine L; Hayes, Richard J
swpermute: Permutation tests for Stepped-Wedge Cluster-Randomised Trials. (2019)
Thompson, Jennifer; Davey, Calum; Hayes, Richard; Hargreaves, James; Fielding, Katherine
Conference or Workshop Item
Peripheral neuropathy at first-line failure and on second-line in sub-Saharan Africa. (2015)
Arenas-Pinto, A; Thompson, J; Musoro, G; Musana, H; Lugemwa, A; Kambugu, A; Mweemba, A; Walker, AS; Paton, N; Team., FTET
Assessing sensitivity to assumptions in mixed effects analyses of stepped-wedge trials. (2015)
Davey, C; Thompson, JA
Second-line treatment in sub-Saharan Africa: week 144 follow-up of the EARNEST trial. (2015)
Hakim, J; Thompson, J; Kityo, C; Walker, AS; van Oosterhout, JJ; Hoppe, A; Kambugu, A; Mugyenyi, P; Paton, N; Team., FTET
Neurocognitive function in patients failing first-line ART in Africa and responses to second-line. (2015)
Kambugu, A; Thompson, J; Hakim, J; Tumukunde, D; van Oosterhout, JJ; Hoppe, A; Kwobah, C; Walker, AS; Paton, N; Team., FTET
Differences in Resistance Mutations in Non-B Subtypes at First-line Failure in Africa. (2015)
Kityo, C; Walker, AS; Nankya, I; Hoppe, A; Thompson, J; Bertagnolio, S; Easterbrook, PJ; Mugyenyi, P; Paton, N; Team., FTET
Impact of NRTI Cross-Resistance on Second-line PI + NRTI Therapy Outcomes in Africa. (2015)
Paton, N; Thompson, J; Bagenda, L; Hakim, J; van Oosterhout, JJ; Kambugu, A; Hoppe, A; Walker, AS; Team., FTET
Considering the design effect for the stepped wedge trial: what can it tell us? (2015)
Thompson, J; Fielding, K; Hargreaves, J; Copas, A
A reanalysis of the Brazil XpertMTB/RIF stepped wedge trial using a novel cluster summary analysis method. (2016)
Thompson, JA; Davey, C; Fielding, K; Hargreaves, J; Hayes, RJ
The optimal design of the stepped wedge trial and a comparison to other trial designs. (2017)
Thompson, JA; Fielding, K; Hargreaves, J; Copas, A
Implications of Misspecifed Mixed Effect Models in Stepped Wedge Trial Analysis: How Wrong Can It Be? (2016)
Thompson, JA; Fielding, KL; Davey, C; Aiken, AM; Hargreaves, JR; Hayes, RJ
Effect of PI Resistance Mutations on Viral Load in Patients on PI Monotherapy. (2016)
Thompson, JA; Kityo, C; Walker, AS; Hakim, J; van Oosterhout, JJ; Siika, A; Mweemba, A; van Den Eede, P; Dunn, DT; Paton, N; ForTheEarnestTrialTeam